Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19666780 | 0.91 | MAPT (0.40) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8402794 | 0.89 | ALDH1A1 (0.40) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8400705 | 0.89 | ALDH1A1 (0.40) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4383570 | 0.80 | CA12 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29225453 | 0.78 | ALOX5 (0.37) | HSD17B10GAAALDH1A1HPGDMEN1 | |
| SCHEMBL19677653 | 0.78 | NR1H2 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9396779 | 0.77 | PTPN1 (0.53) | NR1H2NR1H3SMN1; SMN2CYP3A4TDP1 | |
| SCHEMBL19677652 | 0.74 | NR1H2 (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5590666 | 0.72 | LDHA (0.36) | CA1CA2MAPTALOX15TSHR | |
| SCHEMBL31741854 | 0.71 | CYP1A2 (0.54) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10053407-B2 | Crystalline cannabidivarin | S&B Pharma, Inc. (US) | 2018-08-21 | — | — | US | disclosed |
| US-20170349517-A1 | Crystalline Cannabidivarin | S&B PHARMA, INC., DBA NORAC PHARMA | 2017-12-07 | — | — | US | disclosed |
| US-20170349517-A1 | Crystalline Cannabidivarin | S&B PHARMA, INC., DBA NORAC PHARMA | 2017-12-07 | — | — | US | disclosed |
| US-20170349517-A1 | Crystalline Cannabidivarin | S&B PHARMA, INC., DBA NORAC PHARMA | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349517-A1 | Crystalline Cannabidivarin | CNR2, CNR1, NCSTN | CA12 621/4885CA1 1421/4885CA2 2266/4885 |
| US-10053407-B2 | Crystalline cannabidivarin | CNR2, CNR1, NCSTN | CA12 621/4885CA1 1421/4885CA2 2266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.